Reversal of several aging pathways & diseases

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

George Church

Founding Core Faculty & Lead, Synthetic Biology, Wyss Institute at Harvard University

Reversal of several aging pathways & diseases

Phil Newman

Editor-in-Chief

Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

This field is hidden when viewing the form
GlycanAge teams up with Japan on aging science

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form